Breakthrough in Pancreatic Cancer Treatment: Researchers Develop New Nanostimulants for Immune System Activation

Strategic Insights -

Researchers at Donghua University have made a significant discovery in the field of oncology, developing a new class of nanostimulants that can effectively activate the immune system in the treatment of pancreatic cancer. The study, published in Materials Today Bio, highlights the potential of these nanostimulants in modulating the tumor microenvironment and inducing a potent antitumor immune response.

Key Takeaways:

  • Pancreatic cancer is a highly aggressive malignancy with a poor prognosis due to its complex tumor microenvironment.
  • The researchers developed ECM-degradable semiconducting polymer nanostimulants (SPNs) that can achieve profound tumor penetration and modulate the tumor immune microenvironment.
  • The SPNs were constructed by loading two immune drugs: toll-like receptor 7/8 agonist (R848) and indoleamine 2,3-dioxygenase inhibitor (NLG919), onto singlet oxygen (O)-responsive SPNs, and modifying their surface with hyaluronidase (HAase).
  • Upon accumulation at orthotopic pancreatic tumor sites, HAase-mediated degradation of the ECM significantly enhances the penetration of nanomedicine into the tumor and facilitates the infiltration of immune cells.
  • The SPNs produce O upon sono-activation, which is used for sonodynamic therapy of deep-seated pancreatic tumors and induces immunogenic cell death (ICD) in tumor cells.
  • The study presents an ECM-degradable semiconducting polymer nanostimulant for multifaceted remodeling of the tumor microenvironment, enabling effective and precise immunotherapy of deep-seated orthotopic tumors.

Statistics:

  • 33% inhibition of tumor growth in mouse models
  • 90% suppression of tumor metastases in mouse models
  • The study's novel nanostimulants demonstrate a multifaceted remodeling mechanism, enabling controlled and precise release of the two immune drugs at the tumor site.

Sources:

  • "Extracellular matrix-degradable polymer nanostimulants elicit potent immune responses in orthotopic pancreatic cancer via sono-activatable dual-drug synergism." (Materials Today Bio, 2025;33:101954)
  • Danling Cheng et al. (Donghua University, State Key Laboratory of Advanced Fiber Materials)
  • Elsevier (Materials Today Bio, Radarweg 29, 1043 Nx Amsterdam, Netherlands)
  • NewsRx LLC (2025 Nanotechnology Weekly)